New brain aneurysm device shows promise in major trial

NCT ID NCT05831202

Ongoing Disease control Sponsor: Galaxy Therapeutics INC Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device called SEAL™ that is placed inside a brain aneurysm to block blood flow and prevent rupture. About 279 adults with unruptured or recently ruptured aneurysms are taking part. The goal is to see if the device safely and effectively seals the aneurysm within 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SEAL™ Saccular Endovascular Aneurysm Lattice System (a medical device placed inside the aneurysm to block blood flow)
What this could lead to: If successful, this device could offer a safer, more effective way to treat brain aneurysms and reduce the need for repeat procedures.
What could go wrong: This is a pivotal trial, but results are not yet final. The device may not work for all aneurysm types, and risks like vessel narrowing or incomplete blockage remain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACRANIAL ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRACRANIAL ANEURYSM

Contacts and locations

Locations

Endeavor Health - Evanston Hospital

Evanston, Illinois, 60201, United States
Endeavor Health - Northwest Community Hospital

Arlington Heights, Illinois, 60005, United States
Endeavor Health- Edward Hospital

Naperville, Illinois, 60540, United States
NYU Langone Health

New York, New York, 10016, United States
Stony Brook University Hospital

Stony Brook, New York, 11794, United States
The Cooper Health System

Camden, New Jersey, 08103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.